vimarsana.com


Mirimus Named A Winner in $6M XPRIZE Rapid COVID Testing Competition
Mirimus one of five finalists from the main track eligible to receive $1 million
Pioneering SalivaClear pooled testing platform is designed to provide frequent, high-quality, low-cost detection of SARS-CoV-2, the virus that causes COVID-19
News provided by
Share this article
Share this article
NEW YORK, March 16, 2021 /PRNewswire/ -- Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced it has been named as one of five winners in XPRIZE Rapid COVID Testing for its pioneering SalivaClear
™ COVID-19 pooled saliva testing platform. The SalivaClear platform is composed of three key elements – saliva-based sampling, pooled testing and gold-standard PCR molecular diagnostics – that, when combined, enable frequent, high-quality, high-throughput, low-cost detection of SARS-CoV-2, the virus that causes COVID-19.

Related Keywords

Prem Premsrirut ,Ingrid Mezo ,Johanna Bennett ,Mirimus Inc ,Surveillance Testing Program For Asymptomatic ,Surveillance Testing Program ,Next Billion ,Next Gen Mask Challenge ,Mirimus ,Inc ,ஜோஹன்னா பென்னட் ,கண்காணிப்பு சோதனை ப்ரோக்ர்யாம் ,அடுத்தது பில்லியன் ,அடுத்தது கேன் முகமூடி சவால் ,இன்க் ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.